Epigenetic changes as a common trigger of muscle weakness in congenital myopathies

Exercise training and DNA methylation in humans

(2014) S. Voisin et al.   Acta Physiologica

Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer

(2014) M Wang et al.   BRITISH JOURNAL OF CANCER

Epigenetic adaptation to regular exercise in humans

(2014) Charlotte Ling et al.   DRUG DISCOVERY TODAY

MicroRNA-126 modulates the tumor microenvironment by targeting calmodulin-regulated spectrin-associated protein 1 (Camsap1)

(2014) XIN SUN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

(2014) Katrina J. Falkenberg et al.   NATURE REVIEWS DRUG DISCOVERY

HDAC4: mechanism of regulation and biological functions

(2014) Zhengke Wang et al.   Epigenomics

DNA Methyltransferases: A Novel Target for Prevention and Therapy

(2014) Dharmalingam Subramaniam et al.   Frontiers in Oncology

Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression

(2013) Gaëlle Bruneteau et al.   BRAIN

MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress

(2013) Zhan-Peng Huang et al.   CIRCULATION RESEARCH

RyR1 Deficiency in Congenital Myopathies Disrupts Excitation-Contraction Coupling

(2013) Haiyan Zhou et al.   HUMAN MUTATION

Defective Regulation of MicroRNA Target Genes in Myoblasts from Facioscapulohumeral Dystrophy Patients

(2013) Petr Dmitriev et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Early Development of Hyperparathyroidism Due to Loss ofPTHTranscriptional Repression in Patients With HNF1β Mutations?

(2013) Silvia Ferrè et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Congenital myopathies – Clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom

(2013) L. Maggi et al.   NEUROMUSCULAR DISORDERS

Variable Myopathic Presentation in a Single Family with Novel Skeletal RYR1 Mutation

(2013) Ruben Attali et al.   PLoS One

HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration

(2013) Michal Mielcarek et al.   PLOS BIOLOGY

Acute Exercise Remodels Promoter Methylation in Human Skeletal Muscle

(2012) Romain Barrès et al.   Cell Metabolism

Regulation of mammalian DNA methyltransferases: a route to new mechanisms

(2011) Hélène Denis et al.   EMBO REPORTS

Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy

(2011) Ning Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Unknown

(2011) Silvia Consalvi et al.   MOLECULAR MEDICINE

Core Myopathies

(2011) Heinz Jungbluth et al.   Seminars in Pediatric Neurology

RYR1 mutations are a common cause of congenital myopathies with central nuclei

(2010) J.M. Wilmshurst et al.   ANNALS OF NEUROLOGY

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

(2010) J Zhang et al.   BRITISH JOURNAL OF CANCER

Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion

(2010) Nigel F. Clarke et al.   HUMAN MUTATION

Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene

(2010) Haiyan Zhou et al.   NEUROMUSCULAR DISORDERS

Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization

(2010) J. A. Bevilacqua et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486

(2010) E. M. Small et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DNA Transfection of Mammalian Skeletal Muscles using In Vivo Electroporation

(2009) Marino DiFranco et al.   Jove-Journal of Visualized Experiments

Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm

(2008) S TREVES et al.   CURRENT OPINION IN PHARMACOLOGY

Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores

(2008) Nicole Monnier et al.   HUMAN MUTATION

microRNAs and muscle disorders

(2008) J.-F. Chen et al.   JOURNAL OF CELL SCIENCE